Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Food Allergies

Main Article Content

Michael Blaiss
Michael Cork
Peter Lio
Aharon Kessel
Liza Takiya
John Werth
Michael O'Connell
Chuanbo Zang
Jonathan Spergel

Keywords

Atopic Dermatitis, Crisaborole, Food Allergies

Abstract

Abstract not available.

References

1. Dharmage SC et al. Curr Opin Allergy Clin Immunol. 2004;4(5):379-385.

2. Werfel T, Breuer K. Curr Opin Allergy Clin Immunol. 2004;4(5):379-385.

3. Robison RG, Singh AM. J Allergy Clin Immunol Pract. 2019;7(1):35-39.

4. Eucrisa (crisaborole) ointment, 2%, for topical use [package insert]. New York, NY: Pfizer Labs; April 2020.

5. Paller AS et al. J Am Acad Dermatol. 2016;75(3):494-503.e496.

6. Hanifin JM, Rajka G. Acta Derm Venereol. 1980;60(92):44-47.

7. Yosipovitch G et al. Itch. 2018;3:e13.

Most read articles by the same author(s)